Goal-Setting Method and Goal Attainment Measures in Physical Therapy for Stroke Patients : a Systematic Review
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-11-30
著者
-
Saito Hideyuki
Department of Clinical Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto
-
Iijima Setsu
Comprehensive Human Sciences University Of Tsukuba
-
Saito Hideyuki
Department Of Rehabilitation Tsukuba Memorial Hospital
-
Yoshino Takako
Home-visit Nursing Station Pallium
-
Ohashi Yukari
Department Of Physical Therapy School Of Health Sciences Ibaraki Prefectural University Of Health Sc
-
KAMIOKA YUMIKO
Department of Physical Therapy, School of Health Sciences, Ibaraki Prefectural University of Health
-
SUGAYA KIMIKO
Department of Physical Therapy, Ibaraki Prefectural University of Health Sciences Hospital
-
Sugaya Kimiko
Department Of Physical Therapy Ibaraki Prefectural University Of Health Sciences Hospital
-
Kamioka Yumiko
Department Of Physical Therapy School Of Health Sciences Ibaraki Prefectural University Of Health Sc
-
SAITO Hideyuki
Department of Clinical Pharmaceutical Sciences, Faculty of Life Science, Kumamoto University
関連論文
- Association of SLCO1B3 Polymorphism with Intracellular Accumulation of Imatinib in Leukocytes in Patients with Chronic Myeloid Leukemia
- P-Glycoprotein Mediates Efflux Transport of Darunavir in Human Intestinal Caco-2 and ABCB1 Gene-Transfected Renal LLC-PK1 Cell Lines
- Acute and chronic metabolic acidosis interferes with aquaporin-2 translocation in the rat kidney collecting ducts
- Methotrexate-Loxoprofen Interaction : Involvement of Human Organic Anion Transporters hOAT1 and hOAT3
- Common single nucleotide polymorphisms of the MDR1 gene have on influence on its mRNA expression level of normal kidney cortex and renal cell carcinoma in Japanese nephrectomized patients
- Relationship between an effective dose of imatinib, body surface area, and trough drug levels in patients with chronic myeloid leukemia
- Contribution of BCR-ABL-independent activation of ERK1/2 to acquired imatinib resistance in K562 chronic myeloid leukemia cells
- Involvement of Specific Transport System of Renal Basolateral Membranes in Distribution of Nicotine in Rats
- TRANSPORT CHARACTERISTICS AND CYTOTOXICITY OF AMINOGLYCOSIDE ANTIBIOTICS IN CULTURED KIDNEY EPITHELIAL CELL LINE (LLC-PK_1)
- Goal-Setting Method and Goal Attainment Measures in Physical Therapy for Stroke Patients : a Systematic Review
- Rat Renal Organic Anion Transporter rOAT1 Mediates Transport of Urinary-Excreted Cephalosporins, but not of Biliary-Excreted Cefoperazone
- Evaluation of Percutaneous Absorption of Midazolam by Terpenes
- High-Performance Liquid Chromatographic Assay for the Determination of Nilotinib in Human Plasma
- Na^+-dependent uptake of 1, 5-anhydro-D-glucitol via the transport systems for D-glucose and D-mannose in the kidney epithelial cell line, LLC-PK_1
- Assessment of Adverse Reactions and Pharmacokinetics of Ribavirin in Combination with Interferon α-2b in Patients with Chronic Hepatitis C
- Prevalence and Factors Associated with Tinnitus : A Community-Based Study of Japanese Elders
- Prospective evaluation of pharmacokinetically guided dosing of carboplatin in Japanese patients with cancer
- Enhanced renal accumulation of cisplatin via renal organic cation transporter deteriorates acute kidney injury in hypomagnesemic rats
- Decreased Expression of Glucose and Peptide Transporters in Rat Remnant Kidney
- Decreased Cyclosporin A Concentrations in the Absorption Phase Using Microemulsion Preconcentrate Formulation in Rats with Cisplatin-Induced Acute Renal Failure(Biopharmacy)
- The Relationship between Treatment Time of Gemcitabine and Development of Hematologic Toxicity in Cancer Patients
- Alleviation of cisplatin-induced acute kidney injury using phytochemical polyphenols is accompanied by reduced accumulation of indoxyl sulfate in rats
- Effects of genetic variants in SLC22A2 organic cation transporter 2 and SLC47A1 multidrug and toxin extrusion 1 transporter on cisplatin-induced adverse events
- Distinct Interaction of Nilotinib and Imatinib with P-Glycoprotein in Intracellular Accumulation and Cytotoxicity in CML Cell Line K562 Cells